We are live on ! Find out more
PFO

Pathstone Family Office Portfolio holdings

AUM $13.1B
1-Year Est. Return 21.02%
This Fund
S&P 500
This Quarter Est. Return
+3.12%
1 Year Est. Return
+21.02%
3 Year Est. Return
+39.27%
5 Year Est. Return
+59.47%
10 Year Est. Return
+236.85%
AUM
$848M
AUM Growth
+$61.7M
Cap. Flow
+$46.7M
Cap. Flow %
5.51%
Top 10 Hldgs %
57.15%
Holding
999
New
86
Increased
189
Reduced
130
Closed
344

Top Buys

Rank Stock Value
1
IWB icon
iShares Russell 1000 ETF
IWB
+$10.4M
2
TJX icon
TJX Companies
TJX
+$8.24M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$4.03M
4
AAPL icon
Apple
AAPL
+$3.4M
5
CARG icon
CarGurus
CARG
+$2.58M

Sector Composition

Rank Sector Weight
1 Financials 24.85%
2 Technology 11.23%
3 Consumer Discretionary 9.7%
4 Communication Services 3.67%
5 Industrials 3.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EEFT icon
701
Euronet Worldwide
EEFT
$2.72B
-29
Closed -$4K
EEMS icon
702
iShares MSCI Emerging Markets Small-Cap ETF
EEMS
$349M
$0 ﹤0.01%
17
EG icon
703
Everest Group
EG
$14.5B
-19
Closed -$4K
EGP icon
704
EastGroup Properties
EGP
$11.2B
-35
Closed -$4K
EMB icon
705
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$0 ﹤0.01%
+5
New +$551
ENOV icon
706
Enovis
ENOV
$1.68B
-45
Closed -$2K
ENS icon
707
EnerSys
ENS
$6.78B
-61
Closed -$4K
ENTG icon
708
Entegris
ENTG
$18.1B
-61
Closed -$2K
EQIX icon
709
Equinix
EQIX
$101B
-6
Closed -$3K
ESNT icon
710
Essent Group
ESNT
$6.08B
-62
Closed -$3K
ESPR
711
DELISTED
Esperion Therapeutics
ESPR
-60
Closed -$2K
ESRT icon
712
Empire State Realty Trust
ESRT
$872M
-173
Closed -$3K
EUFN icon
713
iShares MSCI Europe Financials ETF
EUFN
$4.14B
-8,666
Closed -$157K
EVH icon
714
Evolent Health
EVH
$348M
-142
Closed -$2K
EW icon
715
Edwards Lifesciences
EW
$49.6B
-39
Closed -$2K
EWBC icon
716
East-West Bancorp
EWBC
$17.9B
-76
Closed -$4K
FANG icon
717
Diamondback Energy
FANG
$57.1B
-56
Closed -$5.85K
FAST icon
718
Fastenal
FAST
$54.7B
-96
Closed -$2K
KYNB
719
Kyntra Bio
KYNB
$27.2M
-3
Closed -$3K
FIVN icon
720
FIVE9
FIVN
$2.11B
-70
Closed -$4K
FIX icon
721
Comfort Systems
FIX
$60.9B
-54
Closed -$3K
FMX icon
722
Fomento Económico Mexicano
FMX
$43.6B
-59
Closed -$5K
FNF icon
723
Fidelity National Financial
FNF
$13.9B
-470
Closed -$16K
FORM icon
724
FormFactor
FORM
$8.28B
-171
Closed -$3K
G icon
725
Genpact
G
$5.96B
-111
Closed -$4K

Similar funds

Pathstone Family Office's Q2 2019 Portfolio in Review

As of Q2 2019, Pathstone Family Office held 999 positions worth $848M, up 7.8% from $786M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Pathstone Family Office deployed $46.7M of net new capital in Q2 2019, opening 86 new positions and adding to 189 existing holdings. Its largest new stake was Primerica: 18,415 shares worth $2.21M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Merck, an estimated $3.89M trimmed.

  • Pathstone Family Office's largest Q2 2019 buy was Primerica: 18,415 shares worth $2.21M.
  • Pathstone Family Office added most to iShares Russell 1000 ETF in Q2 2019, an estimated $10.4M increase.
  • Pathstone Family Office's biggest Q2 2019 reduction was Merck, cutting an estimated $3.89M.
  • Pathstone Family Office fully exited Xylem in Q2 2019, selling an estimated $983K.
  • Pathstone Family Office's ten largest holdings make up 57% of its $848M portfolio in Q2 2019.
  • Pathstone Family Office opened 86 new positions and closed 344 in Q2 2019.
  • Pathstone Family Office's portfolio value rose 7.8% quarter-over-quarter to $848M.

Based on Pathstone Family Office's 13F filing for Q2 2019, filed 14 Aug 2019.